A comparison of critical errors, overall errors, training/teaching time, and preference attributes of the ELLIPTA versus BREEZHALER dry powder inhalers (DPIs) in adult participants with asthma

Trial Identifier: 213306
Sponsor: GlaxoSmithKline
Collaborator:
N/A
Start Date: April 2021
Primary Completion Date: July 2021
Study Completion Date: July 2021
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Netherlands ENSCHEDE, Netherlands, 7512 KZ
Netherlands NIJVERDAL, Netherlands, 7442 LS
Netherlands ROTTERDAM, Netherlands, 3051 GV